Topic
Human serum albumin
About: Human serum albumin is a research topic. Over the lifetime, 9402 publications have been published within this topic receiving 269029 citations. The topic is also known as: serum albumin & ALB.
Papers published on a yearly basis
Papers
More filters
••
TL;DR: It was found that the hydroxyls substituted on aromatic ring of the drugs play an important role in the changes of protein's secondary structure after interaction with the three drugs.
460 citations
••
TL;DR: The structure of the HSA-hemin-myristate complex (PDB ID 1o9x) reveals the key polar and hydrophobic interactions that determine the hemin-binding specificity of HSA.
Abstract: Human serum albumin (HSA) is an abundant plasma protein that binds a wide variety of hydrophobic ligands including fatty acids, bilirubin, thyroxine and hemin. Although HSA-heme complexes do not bind oxygen reversibly, it may be possible to develop modified HSA proteins or heme groups that will confer this ability on the complex. We present here the crystal structure of a ternary HSA-hemin-myristate complex, formed at a 1:1:4 molar ratio, that contains a single hemin group bound to subdomain IB and myristate bound at six sites. The complex displays a conformation that is intermediate between defatted HSA and HSA-fatty acid complexes; this is likely to be due to low myristate occupancy in the fatty acid binding sites that drive the conformational change. The hemin group is bound within a narrow D-shaped hydrophobic cavity which usually accommodates fatty acid; the hemin propionate groups are coordinated by a triad of basic residues at the pocket entrance. The iron atom in the centre of the hemin is coordinated by Tyr161. The structure of the HSA-hemin-myristate complex (PDB ID 1o9x) reveals the key polar and hydrophobic interactions that determine the hemin-binding specificity of HSA. The details of the hemin-binding environment of HSA provide a structural foundation for efforts to modify the protein and/or the heme molecule in order to engineer complexes that have favourable oxygen-binding properties.
458 citations
••
TL;DR: This work presents the first high-resolution crystal structures of HSA complexed with two important unsaturated fatty acids, the monounsaturated oleic acid and the polyunsaturated arachidonic acid, observed to occupy the seven binding sites distributed across the protein that are also bound by medium and long-chain saturated fatty acids.
455 citations
••
TL;DR: The challenge now is to use the new structural information to design experiments that will identify the physiologically important binding sites on HSA and provide a much richer description of fatty acid interactions with the protein.
453 citations
•
TL;DR: Some results suggest the presence of more than the three binding sites for drugs on the albumin surface studied with diazepam, digitoxin and warfarin, as well as improving the binding of the radioactively labeled markers.
Abstract: Human serum albumin can be immobilized in spherical, macroporous microparticles of polyacrylamide of about 1 µm in diameter with retention of its native properties. It has been shown that diazepam, digitoxin and warfarin independently bind to albumin and can conveniently be used as markers of three separate, discrete binding sites on albumin. A simple technique has been devised by which the capacity of about 140 drugs and other compounds to affect the binding of the radioactively labeled markers has been studied. Some drugs, e.g. antirheumatic drugs of the isopropionic acid-type, some antidiabetic agents, penicillin derivatives, benzodiazepines, tryptophan, dansylsarcosine, and suiphobromophthalein efficiently displace diazepam. Other drugs, e.g., some diuretics, sulpha drugs, phenytoin, salicylic acid and butazone derivatives, azapropazoe, bilirubin, and dansylamide displace warfarin. Displacement of digitoxin is less common. In some cases the binding of the markers is improved, e.g., tamoxifen increases the binding of warfarin. Both competitive and allosteric mechanisms are responsible for the changed binding of the markers. Some results suggest the presence of more than the three binding sites for drugs on the albumin surface studied with diazepam, digitoxin and warfarin.
447 citations